Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma.
Versluis JM, Blankenstein SA, Dimitriadis P, Wilmott JS, Elens R, Blokx WAM, van Houdt W, Menzies AM, Schrage YM, Wouters MWJM, Sanders J, Broeks A, Scolyer RA, Suijkerbuijk KPM, Long GV, Akkooi ACJV, Blank CU. Versluis JM, et al. Among authors: blankenstein sa. J Immunother Cancer. 2024 Apr 27;12(4):e008125. doi: 10.1136/jitc-2023-008125. J Immunother Cancer. 2024. PMID: 38677880 Free PMC article.
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Blankenstein SA, Bonenkamp JJ, Aarts MJB, van den Berkmortel FWPJ, Blank CU, Blokx WAM, Boers-Sonderen MJ, van den Eertwegh AJM, Franken MG, de Groot JWB, Haanen JBAG, Hospers GAP, Kapiteijn EW, van Not OJ, Piersma D, van Rijn RS, Suijkerbuijk KPM, van der Veldt AAM, Vreugdenhil G, Westgeest HM, Wouters MWJM, van Akkooi ACJ. Blankenstein SA, et al. Ann Surg Oncol. 2023 Jan;30(1):573-586. doi: 10.1245/s10434-022-12600-2. Epub 2022 Oct 6. Ann Surg Oncol. 2023. PMID: 36203067
18F-FDG PET/CT During Neoadjuvant Targeted Therapy in Prior Unresectable Stage III Melanoma Patients: Can (Early) Metabolic Imaging Predict Histopathologic Response or Recurrence?
van der Hiel B, Blankenstein SA, Aalbersberg EA, Wondergem M, Stokkel MPM, van de Wiel BA, Klop WMC, van Akkooi ACJ, Haanen JB. van der Hiel B, et al. Among authors: blankenstein sa. Clin Nucl Med. 2022 Jul 1;47(7):583-589. doi: 10.1097/RLU.0000000000004217. Epub 2022 Apr 22. Clin Nucl Med. 2022. PMID: 35452004
Postoperative radiotherapy in stage I-III Merkel cell carcinoma.
Levy S, Blankenstein SA, Grünhagen DJ, Jalving M, Hamming-Vrieze O, Been LB, Tans L, van Akkooi ACJ, Tesselaar MET. Levy S, et al. Among authors: blankenstein sa. Radiother Oncol. 2022 Jan;166:203-211. doi: 10.1016/j.radonc.2021.11.017. Epub 2021 Nov 25. Radiother Oncol. 2022. PMID: 34838887 Free article.
Neoadjuvant Cytoreductive Treatment With BRAF/MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single-arm, Open-label Phase II Trial.
Blankenstein SA, Rohaan MW, Klop WMC, van der Hiel B, van de Wiel BA, Lahaye MJ, Adriaansz S, Sikorska K, van Tinteren H, Sari A, Grijpink-Ongering LG, van Houdt WJ, Wouters MWJM, Blank CU, Wilgenhof S, van Thienen JV, van Akkooi ACJ, Haanen JBAG. Blankenstein SA, et al. Ann Surg. 2021 Aug 1;274(2):383-389. doi: 10.1097/SLA.0000000000004893. Ann Surg. 2021. PMID: 33843797 Clinical Trial.
Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy.
Blankenstein SA, Aarts MJB, van den Berkmortel FWPJ, Boers-Sonderen MJ, van den Eertwegh AJM, Franken MG, de Groot JWB, Haanen JBAG, Hospers GAP, Kapiteijn E, Piersma D, van Rijn RS, Suijkerbuijk KPM, Ten Tije AJ, van der Veldt AAM, Vreugdenhil G, Wouters MWJM, van Akkooi ACJ. Blankenstein SA, et al. Cancers (Basel). 2020 May 7;12(5):1176. doi: 10.3390/cancers12051176. Cancers (Basel). 2020. PMID: 32392717 Free PMC article.
Broadening indications for neoadjuvant immunotherapy.
Blankenstein SA, van Akkooi ACJ. Blankenstein SA, et al. Br J Dermatol. 2020 Sep;183(3):421-422. doi: 10.1111/bjd.18873. Epub 2020 Feb 3. Br J Dermatol. 2020. PMID: 32017031 No abstract available.
Primary Melanoma: from History to Actual Debates.
Testori AAE, Blankenstein SA, van Akkooi ACJ. Testori AAE, et al. Among authors: blankenstein sa. Curr Oncol Rep. 2019 Dec 19;21(12):112. doi: 10.1007/s11912-019-0843-x. Curr Oncol Rep. 2019. PMID: 31858280 Review.
Surgery for Metastatic Melanoma: an Evolving Concept.
Testori AAE, Blankenstein SA, van Akkooi ACJ. Testori AAE, et al. Among authors: blankenstein sa. Curr Oncol Rep. 2019 Nov 6;21(11):98. doi: 10.1007/s11912-019-0847-6. Curr Oncol Rep. 2019. PMID: 31696407 Review.
12 results